Search
for
Sort by
Research 181–210 of 184
- A mutation in the type II hair keratin KRT86 gene in a Han family with monilethrix
- Gene detection in a family with monilethrix and treatment with 5% topical minoxidil
- Platelet-Rich Plasma in Dermatology: New Insights on the Cellular Mechanism of Skin Repair and Regeneration
- Clinicopathologic Case 2: Multiple Intraoral White Lesions in a 55-year-old Female
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Dermatological manifestations associated with COVID‐19 and COVID‐19 vaccination: results from the Lebanese COVID registry
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- Caution in the time of rashes and COVID-19
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Cutaneous Manifestations of COVID-19
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Drug eruptions in dermatology
- Concurrence of Palmoplantar Psoriasiform Eruptions and Hair Loss during Carbamazepine Treatment
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
- Cutaneous Reactions to Drugs
- Treatment of Alopecia Areata With Tofacitinib
- Cutaneous drug reactions
- Drug-Induced Skin, Nail and Hair Disorders
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Cutaneous signs in COVID ‐19 patients: A review
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Chikungunya virus infection in the skin: histopathology and cutaneous immunological response
- Cutaneous Manifestations of COVID-19: A Brief Review of a Possible Diagnostic Tool
- A clinical study of cutaneous adverse drug reactions